HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...
The human papillomavirus (HPV) is the most common sexually transmitted infection, and most people will have exposure at some ...
Dr Nur Adila Mokhtar, Consultant Clinical Oncologist at OncoCare Cancer Centre Malaysia, shares, “The HPV vaccine is ...
India faces a rising health issue with millions of cervical cancer patients, largely caused by the HPV virus. The HPV vaccine ...
The FDA's approval last spring of cervical cancer tests which allow patients to collect their own samples could increase ...
Cervical cancer, primarily caused by a persistent infection with human papillomavirus (HPV), is a preventable disease, ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.
Dr. Theresa Byrd, dean of UT Tyler School of Health Professions, said with the HPV vaccine is available, it is the best way ...